IRMD

Iradimed CORP

+$19.8M

Net Activity

Institutions Holding

226

Popularity Rank

#2600

Avg Weight

0.12%

Total Value

$735.8M

Ownership Trend

226 institutions currently hold IRMD, with 115 net buyers and 89 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

89

Net Buying Institutions

115

Key Holders

View all 226 holding institutions

Quarterly Activity

Recent Activity

+$336.6M

Total Buy Value

$389.2M

Total Sell Value

New buy28
Trim69
Add87
Sold out20

115

Net Buyers

89

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

1

Filings (90d)

$285K

Total Est. Value

3K shares

Planned Shares

Last Filed 2026-06-04
FilerFiling DateEst. Value
Scharen-Guivel Hilda Frederique2026-06-04$285K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

FAQ

Who are the top institutional investors holding IRADIMED CORP (IRMD)?
Major stakeholders currently include BlackRock, Inc. ($93.2M), Renaissance Technologies LLC ($42.4M), Copeland Capital Management, LLC ($34.6M). Based on the latest 13F filings, there are a total of 226 tracked investment funds and institutions maintaining positions in IRMD.
What is the overall institutional sentiment toward IRMD recently?
Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $19.8M, driven by 115 managers accumulating shares while 89 reduced their exposure.
Which institutions have been selling or reducing their IRMD positions?
In the latest period, 69 funds trimmed their holdings, and 20 managers completely exited their positions. The aggregate reported sell value was $389.2M.
Are there any notable investors adding IRMD to their portfolios?
Yes, buying activity remains notable. 28 institutions opened new positions in {ticker}, and 87 existing holders added to their shares. The total reported buy value for the quarter amounted to $336.6M.

Related Stocks